Literature DB >> 18221284

Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse.

Fernando Silva Carneiro1, Fernanda R C Giachini2, Victor V Lima3, Zidonia N Carneiro3, Romulo Leite3, Edward W Inscho3, Rita C Tostes4, R Clinton Webb3.   

Abstract

INTRODUCTION: Erectile dysfunction (ED) in diabetes is associated with autonomic neuropathy and endothelial dysfunction. Whereas the nonadrenergic-noncholinergic (NANC)/neurogenic nitric oxide pathway has received great attention in diabetes-associated ED, few studies have addressed sympathetic overactivity. AIM: To test the hypothesis that adenosine-induced inhibition of adrenergic-mediated contractile responses in mouse corpus cavernosum is impaired in the presence of diabetes.
METHODS: The db/db (obesity and type II diabetes caused by a leptin receptor mutation) mouse strain was used as a model of obesity and type II diabetes, and standard procedures were performed to evaluate functional cavernosal responses. MAIN OUTCOME MEASURES: Increased cavernosal responses to sympathetic stimulation in db/db mice are not associated with impaired prejunctional actions of adenosine.
RESULTS: Electrical field stimulation (EFS)-, but not phenylephrine (PE)-, induced contractions are enhanced in cavernosal strips from db/db mice in comparison with those from lean littermates. Direct effects of adenosine, 2-chloro-adenosine, A(1) receptor agonist C-8031 (N6 cyclopentyladenosine), and sodium nitroprusside are similar between the strips from lean and db/db mice, whereas relaxant responses to acetylcholine and NANC stimulation are significantly impaired in the cavernosal strips from db/db mice. 5'-Iodotubercidin (adenosine kinase inhibitor) and dipyridamole (inhibitor of adenosine transport), as well as the A(1) agonist C-8031, significantly and similarly inhibit contractions induced by stimulation of adrenergic nerves in the cavernosal strips from lean and db/db mice.
CONCLUSIONS: Results from this study suggest that corpora cavernosa from obese and diabetic db/db mice display altered neural-mediated responses that would favor penile detumescence, i.e., increased contractile response to adrenergic nerve stimulation and decreased relaxant responses upon activation of NANC nerves. However, increased cavernosal responses to adrenergic nerve stimulation are not due to impaired negative modulation of sympathetic neurotransmission by adenosine in this diabetic model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18221284      PMCID: PMC3016713          DOI: 10.1111/j.1743-6109.2007.00752.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  49 in total

1.  Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate.

Authors:  F S Facchini; R A Stoohs; G M Reaven
Journal:  Am J Hypertens       Date:  1996-10       Impact factor: 2.689

2.  Impaired contraction and relaxation in the aorta of streptozotocin-diabetic rats.

Authors:  T Utkan; Y Sarioglu; S Yildirim
Journal:  Pharmacology       Date:  1998-04       Impact factor: 2.547

3.  Neural and endothelial nitric oxide synthase activity in rat penile erectile tissue.

Authors:  W G Dail; V Barba; L Leyba; R Galindo
Journal:  Cell Tissue Res       Date:  1995-10       Impact factor: 5.249

4.  Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans.

Authors:  P Vollenweider; L Tappy; D Randin; P Schneiter; E Jéquier; P Nicod; U Scherrer
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men.

Authors:  S Gudbjörnsdottir; P Friberg; M Elam; S Attvall; P Lönnroth; B G Wallin
Journal:  Blood Press       Date:  1994-11       Impact factor: 2.835

6.  Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.

Authors:  H A Feldman; I Goldstein; D G Hatzichristou; R J Krane; J B McKinlay
Journal:  J Urol       Date:  1994-01       Impact factor: 7.450

7.  A large proportion of pelvic neurons innervating the corpora cavernosa of the rat penis exhibit NADPH-diaphorase activity.

Authors:  A Schirar; F Giuliano; O Rampin; J P Rousseau
Journal:  Cell Tissue Res       Date:  1994-12       Impact factor: 5.249

8.  Forearm norepinephrine spillover during standing, hyperinsulinemia, and hypoglycemia.

Authors:  D S Paramore; C G Fanelli; S D Shah; P E Cryer
Journal:  Am J Physiol       Date:  1998-11

9.  Adenosine: a new agent in the diagnosis of impotence.

Authors:  S Kiliç; M Salih; K Anafarta; S Baltaci; A Koşar
Journal:  Int J Impot Res       Date:  1994-12       Impact factor: 2.896

10.  A comparison of the relaxation responses of isolated cavernosal smooth muscles by endothelium-independent and endothelium-dependent vasodilators in diabetic men with impotence.

Authors:  S C Kim; S Y Ahn; S H Park; M Y Lee; D Y Uhm
Journal:  J Korean Med Sci       Date:  1995-02       Impact factor: 2.153

View more
  14 in total

Review 1.  Role of adenosine signaling in penile erection and erectile disorders.

Authors:  Prasad V Phatarpekar; Jiaming Wen; Yang Xia
Journal:  J Sex Med       Date:  2010-11       Impact factor: 3.802

Review 2.  Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors.

Authors:  Khaled S Abdelkawy; Kelsey Lack; Fawzy Elbarbry
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

3.  Role of Adenosine Receptor(s) in the Control of Vascular Tone in the Mouse Pudendal Artery.

Authors:  Hicham Labazi; Stephen L Tilley; Catherine Ledent; S Jamal Mustafa
Journal:  J Pharmacol Exp Ther       Date:  2015-12-30       Impact factor: 4.030

4.  GSK-3β function in bone regulates skeletal development, whole-body metabolism, and male life span.

Authors:  J R Gillespie; J R Bush; G I Bell; L A Aubrey; H Dupuis; M Ferron; B Kream; G DiMattia; S Patel; J R Woodgett; G Karsenty; D A Hess; F Beier
Journal:  Endocrinology       Date:  2013-07-31       Impact factor: 4.736

5.  Erectile dysfunction in young non-obese type II diabetic Goto-Kakizaki rats is associated with decreased eNOS phosphorylation at Ser1177.

Authors:  Fernando S Carneiro; Fernanda R C Giachini; Zidonia N Carneiro; Victor V Lima; Adviye Ergul; R Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2010-08-30       Impact factor: 3.802

6.  Murine and rat cavernosal responses to endothelin-1 and urotensin-II Vasoactive Peptide Symposium.

Authors:  Fernando S Carneiro; Zidonia N Carneiro; Fernanda R C Giachini; Victor V Lima; Edson Nogueira; William E Rainey; Rita C Tostes; R Clinton Webb
Journal:  J Am Soc Hypertens       Date:  2008-11

Review 7.  Diabetes, obesity and erectile dysfunction: field overview and research priorities.

Authors:  Kanchan Chitaley; Varant Kupelian; Leslee Subak; Hunter Wessells
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

8.  Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism.

Authors:  Jiaming Wen; Xianzhen Jiang; Yingbo Dai; Yujin Zhang; Yuxin Tang; Hong Sun; Tiejuan Mi; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  J Sex Med       Date:  2010-09       Impact factor: 3.802

9.  TNF-alpha infusion impairs corpora cavernosa reactivity.

Authors:  Fernando S Carneiro; Saiprazad Zemse; Fernanda R C Giachini; Zidonia N Carneiro; Victor V Lima; R Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

10.  Role of neural NO synthase (nNOS) uncoupling in the dysfunctional nitrergic vasorelaxation of penile arteries from insulin-resistant obese Zucker rats.

Authors:  Ana Sánchez; Cristina Contreras; María Pilar Martínez; Belén Climent; Sara Benedito; Albino García-Sacristán; Medardo Hernández; Dolores Prieto
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.